How to Choose a Trustworthy Biospecimen Provider?

  The vast majority of innovative drugs and therapies depend on real-life evidence extracted from Human Biological Specimens (HBS) and their associated data 1. As a result, significant changes started reshaping the biobanking and biospecimen procurement field, making HBS-dependent studies no longer restricted to hospitals or biobank-associated institutes. Today, the continuously growing private sector can…

Read More

6 Cancer Research Advancements Reliant on Human Biospecimens

March 16, 2021 Over the last two decades, oncology research has achieved outstanding results in the way we understand and approach the multifaceted nature of cancer. From immuno-oncology at the forefront to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized,…

Read More

How to Choose the Right Biospecimen for Your Study?

December 2, 2020 When deciding on working with human biospecimens, it is essential to choose the type and format that best fits your project’s final goals. The type of materials (solid tissues/biofluids) and the format in which they are isolated and conserved will define the downstream applications they suit 1. The various types and formats…

Read More

How Patient-Derived Biospecimens Drive the Advancements of Biomedical Research?

Over the last years, the focus of biopharma has moved towards precision medicine and immunologic or genetic-based therapies. This transition requires a more in-depth understanding of the molecular and cellular mechanisms underlying a given pathological condition. Ethically procured human biospecimens from patients with available clinical history and molecular data are an invaluable resource to biomedical…

Read More